Segment Information (Tables)

3 Months Ended

Mar. 31, 2025

Schedule of Segment Reporting Information, by Segment

There are no differences from the Company’s 2024 Form 10-K in the factors used to identify the reportable segments or measurement basis for segment loss. Significant segment expenses, as provided to the CODM, are presented below (in thousands):


	Three Months Ended March 31,
	2025		2024
Research and development payroll-related costs	$	5,232	$	3,028
General and administrative payroll-related costs	2,154		1,549
Clinical trial expenses	6,009		2,195
Chemistry, manufacturing, and controls costs	4,346		4,393
Medical affairs expenses	555		286
Research and development consulting expenses	1,372		832
General and administrative consulting expenses	1,036		1,989
Other segment items1	2,266		(961)
Segment and consolidated net loss	$	22,970	$	13,311

1Other segment items include legal expenses, accounting expenses, IT and facilities expenses, insurance expenses, other operating expenses, interest income, investment income, stock-based compensation expense, depreciation expense, and other income, net.